Figures & data
Table 1. Analytically confirmed cases of methoxetamine.
Table 1. Awareness of new UK guidance on the management of paracetamol poisoning among professional groups and between specialties.
Table 1. Severity of Vipera berus bites in adults and children.
Table 1. Summary of pediatric tizanidine exposures.
Table 1. Characteristics of National Poisons Information Service telephone enquiries relating to quinine.
Table 1. European poisons centres - services provided.
Table 1. ToxIndex calculated for selected exposures reported to GIZ-Nord Poisons Centre in 2011.
Table 1. NPDS data for pesticides and CO over time.
Table 1. Advantages and disadvantages of the Cloud system.
Table 1. Hospitalizations related to gabapentin or pregabalin abuse.
Table 1. Disposition in cases of misuse and abuse of quetiapine.
Table 1. Moderate to severe fire smoke poisonings.
Table 1. Representative drugs for drug classes highly associated with infusion reactions.
Table 1. Association between serum PFOA concentrations and clinical renal and cardiovascular disease.
Table 1. Unintentional pediatric opioid exposures as reported to the Global Toxicosurveillance Network from 2008–2010.
Table 1 Frequency of detection of potential novel psychoactive substances from the two urinals within the festival.
Table 1. The life-time prevalence of misuse of each group of opioid containing medications and the reasons for misuse.
Table 1. Frequency of detection of classical recreational drugs and novel psychoactive substances in anonymous pooled urine samples from street urinals over two consecutive weekends.
Table 1. Enquiries to NPIS involving recreational organic nitrites from January 2008 to October 2012.
Table 1. Clinical characteristics of patients (n = 53) reported to NPIS as having synthetic cannabinoid receptor agonist toxicity by healthcare professionals.
Table 1. Clinical features reported in telephone enquiries related to suspected methoxetamine exposure.
Table 1. Sensitivity1 (percentage of true positive samples detected) and specificity2 (percentage of true negative samples detected) of two drug tests.
Table 1. Summary of results.
Table 1. Laboratory parameters in a case of dabigatran intoxication.